Proposals Due for NCATS Collaborative Pre-Clinical Development Programs

NCATS is accepting proposals to collaborate with its Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists. Proposals are due September 30, 2017.

BrIDGs scientists collaborate with researchers to advance candidate therapeutics for both common and rare diseases into clinical testing. TRND researchers and their collaborators move new therapeutic candidates through pre-clinical testing, from lead optimization to submission of an investigational new drug application.

Learn how to collaborate with BrIDGs.

Learn how to collaborate with TRND.